WOLVERINE TRADING, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q2 2022$7,000
-83.3%
27,200
-67.2%
0.00%
Q1 2022$42,000
+13.5%
82,877
+33.9%
0.00%
Q4 2021$37,000
-60.6%
61,875
-33.8%
0.00%
Q3 2021$94,000
-14.5%
93,511
+55.9%
0.00%
Q2 2021$110,000
-42.7%
60,000
-42.1%
0.00%
Q1 2021$192,000
+82.9%
103,583
+26.2%
0.00%
Q4 2020$105,000
-73.8%
82,100
-59.5%
0.00%
-100.0%
Q3 2020$400,000
-47.7%
202,892
+110.1%
0.00%
-66.7%
Q2 2020$765,000
+136.1%
96,578
+64.2%
0.00%
Q1 2020$324,000
+14.9%
58,802
+11.9%
0.00%
Q4 2019$282,000
-38.6%
52,555
-42.6%
0.00%
-100.0%
Q3 2019$459,000
-44.4%
91,638
-23.1%
0.00%
-50.0%
Q2 2019$825,000
+3.1%
119,122
+3.5%
0.00%0.0%
Q1 2019$800,000
+53.8%
115,103
+30.2%
0.00%0.0%
Q4 2018$520,000
+19.0%
88,399
+52.7%
0.00%
+100.0%
Q3 2018$437,000
+21.1%
57,900
-2.4%
0.00%0.0%
Q2 2018$361,0000.0%59,3000.0%0.00%0.0%
Q1 2018$361,000
-6.0%
59,300
+9.9%
0.00%
-50.0%
Q4 2017$384,000
-7.0%
53,979
-18.2%
0.00%0.0%
Q2 2017$413,00065,9600.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders